Novo Nordisk’s Bold Price Strategy: Volume Over Margin in the Weight-Loss Drug Battle
The pharmaceutical giant Novo Nordisk, once a high-flying market darling, is implementing a dramatic strategic pivot. Facing intense competitive pressure from rival Eli Lilly, the…
